Zymeworks (ZYME) Long-Term Deferred Tax (2021 - 2026)

Zymeworks (ZYME) has 6 years of Long-Term Deferred Tax data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Deferred Tax fell 2.93% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (down 2.93% YoY), and the FY2025 full-year result was $4.7 million, up 7.34% from the prior year.
• Long-Term Deferred Tax steadied at $4.7 million in Q1 2026, from $4.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $4.9 million in Q3 2025 to a low of $1.3 million in Q3 2023.
• A 5-year average of $3.5 million and a median of $3.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax tumbled 56.57% in 2023 and surged 219.85% in 2024, its largest moves.
• Tracing ZYME's Long-Term Deferred Tax over 5 years: stood at $1.3 million in 2022, then jumped by 168.77% to $3.6 million in 2023, then rose by 21.3% to $4.4 million in 2024, then advanced by 7.34% to $4.7 million in 2025, then changed by 0.0% to $4.7 million in 2026.
• Business Quant data shows ZYME's Long-Term Deferred Tax at $4.7 million in Q1 2026, $4.7 million in Q4 2025, and $4.9 million in Q3 2025.